L2 Asset Management, LLC Bristol Myers Squibb CO Transaction History
L2 Asset Management, LLC
- $690 Million
- Q2 2025
A detailed history of L2 Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, L2 Asset Management, LLC holds 9,016 shares of BMY stock, worth $401,572. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,016
Previous 20,400
55.8%
Holding current value
$401,572
Previous $1.24 Million
66.48%
% of portfolio
0.06%
Previous 0.25%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.68 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.07 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.81 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.22 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.15 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $94.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...